tiprankstipranks
Trending News
More News >

Lai Wang Insider Profile

4 Followers
Lai Wang, Global Head of R&D at BeOne Medicines, holds 1.75M shares in BeOne Medicines (Ticker: ONC).
tipranks
Lai Wang

Lai Wang
BeOne Medicines (ONC)
Global Head of R&D

Ranked #52,594 out of 102,596 Corporate Insiders

Profitable Transactions

43%
6 out of 14 Profitable Transactions

Average Return

-0.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$509M
100.00%
A breakdown of Lai Wang's holdings

Insider Roles

BeOne Medicines
(ONC)
Global Head of R&D
Roles that Lai Wang holds in companies

Most Profitable Insider Trade

Stock:
BeOne Medicines
(ONC)
Rating:Informative Sell
Date:Jun 09, 2021 - Jun 09, 2022
Return:+56.60%
The most profitable trade made by Lai Wang

Lai Wang's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BeOne Medicines
Jul 22, 2025
Global Head of R&D
Uninformative Sell
210.00K
$509.02M
Success Rate for
ONC
6 out of 14 profitable transactions on
ONC
43%
Average Return for
ONC
Average return per transaction on
ONC
-0.36%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 21, 2021
Uninformative Buy
$0.00
-
$0.00
Dec 17, 2021
Uninformative Buy
$0.00
-
$0.00
Jun 24, 2022
Uninformative Buy
$0.00
-
$0.00
Jun 20, 2023
Uninformative Buy
$0.00
-
$0.00
Jun 07, 2024
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Lai Wang's performance on stock

Lai Wang insider profile FAQ

What is the percentage of profitable transactions made by Lai Wang?
The percentage of profitable transactions made by Lai Wang is 43%.
    What is the average return per transaction made by Lai Wang?
    The average return per transaction made by Lai Wang is -0.30%.
      What stocks does Lai Wang hold?
      Lai Wang holds: ONC stocks.
        What was Lai Wang’s latest transaction?
        Lai Wang latest transaction was an Uninformative Sell of $210.00K.
          What was Lai Wang's most profitable transaction?
          Lai Wang’s most profitable transaction was an Informative Sell of ONC stock on June 9, 2021. The return on the trade was 56.60%.
            What is Lai Wang's role in BeOne Medicines?
            Lai Wang's role in BeOne Medicines is Global Head of R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.